Ledger.Open graph →
SEC Form D · filed December 10, 2021

Halda Therapeutics, LLC

Offering
$51.0M
Sold
$41.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW HAVEN, CT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Rebecca Frey · Madison, CTDirectorScott Phillips · Cromwell, CTExecTim D. Shannon · Westport, CTExec · DirectorEric Kettani · Mentor, OHExecDavid J. Freibaum · BOSTON, MADirectorErnest H. Pomerantz · Concord, MAExec · DirectorLiam Ratcliffe · Cambridge, MADirectorLeyi Wang · Cambridge, MADirectorSteven A. Tananbaum · New York, NYExec · DirectorMehrdad Arjmand · Madison, WIExecKevin Brennan · BOCA RATON, FLDirectorLiam Ratcliffe · Cambridge, MADirectorLeyi Wang · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗